Phase II study of lutetium-177 labeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 for metastatic castration-resistant prostate cancer

PURPOSE: To assess the efficacy of a single infusion of radiolabeled anti-prostate specific membrane antigen monoclonal antibody J591 ((177)Lu-J591) by PSA decline, measurable disease response, and survival. EXPERIMENTAL DESIGN: In this dual-center phase II study, 2 cohorts with progressive metastat...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Tagawa, Scott T., Milowsky, Matthew I., Morris, Michael, Vallabhajosula, Shankar, Christos, Paul, Akhtar, Naveed H., Osborne, Joseph, Goldsmith, Stanley J., Larson, Steve, Taskar, Neeta Pandit, Scher, Howard I., Bander, Neil H., Nanus, David M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3778101/
https://ncbi.nlm.nih.gov/pubmed/23714732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-0231
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak